Statin Drug May Slow Alzheimer's

Published Online: Thursday, September 1, 2005

Preliminary research suggests that the cholesterol-lowering drug atorvastatin (Lipitor) may help boost thinking ability and control psychiatric symptoms in patients with mild-to-moderate Alzheimer's disease (AD). The study included 67 AD patients who received either atorvastatin or placebo. The patients were evaluated using standard measures of cognitive function, psychiatric symptoms, and the ability to navigate common activities of daily living. They were also tested for changes in blood cholesterol levels. The study, which was conducted at the Sun Health Research Institute in Sun City, Ariz, revealed that "daily administration of 80 mg of atorvastatin calcium significantly reduces circulating cholesterol levels and may have a positive effect on the progressive deterioration of cognitive function and behavior anticipated in mild-to-moderate AD," the researchers said. Two larger, multicenter trials are currently under way to further investigate the possible benefits of atorvastatin treatment in patients with AD.



Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues
$auto_registration$
VSEO N/A